{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:39:24Z","timestamp":1782520764694,"version":"3.54.5"},"reference-count":109,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:00:00Z","timestamp":1668816000000},"content-version":"am","delay-in-days":414,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1053\/j.seminhematol.2021.10.003","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T11:43:12Z","timestamp":1633952592000},"page":"247-253","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Looking beyond VEXAS: Coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome"],"prefix":"10.1053","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1039-4835","authenticated-orcid":false,"given":"Artem","family":"Oganesyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yervand","family":"Hakobyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Georgin-Lavialle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsene","family":"Mekinian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminhematol.2021.10.003_bib0001","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","article-title":"Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease","volume":"383","author":"Beck","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0002","first-page":"keab392","article-title":"VEXAS syndrome in a woman","author":"Barba","year":"2021","journal-title":"Rheumatology"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0003","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1056\/NEJMc2102124","article-title":"Mutant UBA1 and severe adult-onset autoinflammatory disease","volume":"384","author":"Arlet","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0004","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1182\/blood.2020010177","article-title":"Therapeutic options in Vexas syndrome: insights from a retrospective series","volume":"137","author":"Bourbon","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.41743","article-title":"Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS syndrome","volume":"73","author":"Ferrada","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0006","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1182\/blood.2020010286","article-title":"Novel somatic mutations in UBA1 as a cause of VEXAS syndrome","volume":"137","author":"Poulter","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0007","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/annrheumdis-2021-220089","article-title":"Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis","volume":"80","author":"Tsuchida","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0008","first-page":"1","article-title":"Adult-onset autoinflammation caused by somatic mutations in UBA1: a dutch case series of VEXAS patients","author":"van der Made","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0009","first-page":"3591","article-title":"VEXAS syndrome","volume":"137","author":"Grayson","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0010","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1136\/annrheumdis-2017-212515","article-title":"Consensus proposal for taxonomy and definition of the autoinflammatory diseases (AIDS): a delphi study","volume":"77","author":"Ben-Chetrit","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2020.101529","article-title":"Systemic autoinflammatory diseases: clinical state of the art","volume":"34","author":"Georgin-Lavialle","year":"2020","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0012","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.lpm.2018.12.003","article-title":"Autoinflammatory diseases: state of the art","volume":"48","author":"Georgin-Lavialle","year":"2019","journal-title":"Press Medicale"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102421","article-title":"Systemic autoinflammatory diseases","volume":"109","author":"Krainer","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0014","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0015","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the haematological malignancy research network","volume":"105","author":"Smith","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0016","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0017","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1182\/blood-2018-10-844621","article-title":"Genetics of MDS","volume":"133","author":"Ogawa","year":"2019","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0018","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.leukres.2016.05.013","article-title":"Autoimmune and inflammatory diseases associated with chronic myelomonocytic leukemia: a series of 26 cases and literature review","volume":"47","author":"Grignano","year":"2016","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0019","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6604935","article-title":"Risks of myeloid malignancies in patients with autoimmune conditions","volume":"100","author":"Anderson","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0020","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/acr.20504","article-title":"Systemic and immune manifestations in myelodysplasia: a multicenter retrospective study","volume":"63","author":"De Hollanda","year":"2011","journal-title":"Arthritis Care Res"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0021","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/rheumatology\/kev294","article-title":"Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a french multicentre retrospective study","volume":"55","author":"Mekinian","year":"2015","journal-title":"Rheumatol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0022","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00277-018-3302-0","article-title":"Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes","volume":"97","author":"Montoro","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0023","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/S0145-2126(15)30280-0","article-title":"279 frequency of autoantibodies (AAB) in MDS with and without clinical autoimmune disorders (AID)","volume":"39","author":"Fraison","year":"2015","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0024","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/ard.2003.012948","article-title":"Autoimmune manifestations in human myelodysplasia: apositive correlation with interferon regulatory factor-1 (IRF-1) expression","volume":"63","author":"Giannouli","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.seminhematol.2018.05.002","article-title":"Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations","volume":"55","author":"Kipfer","year":"2018","journal-title":"Semin Hematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0026","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1468-3083.2007.02520.x","article-title":"Cutaneous manifestations in relation to immunologic parameters in a cohort of primary myelodysplastic syndrome patients","volume":"22","author":"Dalamaga","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0027","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2141.1995.tb05310.x","article-title":"Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy","volume":"91","author":"Enright","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0028","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1080\/10428194.2019.1599114","article-title":"Autoantibodies in myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"60","author":"Fraison","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0029","doi-asserted-by":"crossref","first-page":"E451","DOI":"10.3324\/haematol.2018.215087","article-title":"Red cell autoimmunization and alloimmunization in myelodysplastic syndromes: prevalence, characteristic and significance","volume":"104","author":"Chhetri","year":"2019","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0030","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s002770100308","article-title":"Red cell antibodies in frequently transfused patients with myelodysplastic syndrome","volume":"80","author":"Stiegler","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0031","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1537-2995.2012.03819.x","article-title":"Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia","volume":"53","author":"Sanz","year":"2013","journal-title":"Transfusion"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0032","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1038\/leu.2008.389","article-title":"Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria","volume":"23","author":"Houwerzijl","year":"2009","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0033","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1002\/ccr3.2987","article-title":"Zinc-induced copper deficiency, sideroblastic anemia, and neutropenia: a perplexing facet of zinc excess","volume":"8","author":"Wahab","year":"2020","journal-title":"Clin Case Reports"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0034","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1182\/blood-2002-01-0256","article-title":"Copper deficiency masquerading as myelodysplastic syndrome","volume":"100","author":"Gregg","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0035","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/jama.1990.03450110087033","article-title":"Excessive zinc ingestion. a reversible cause of sideroblastic anemia and bone marrow depression","volume":"264","author":"Broun","year":"1990","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0036","first-page":"487","article-title":"Alcohol-induced vacuolization in bone marrow cells: ultrastructure and mechanism of formation","volume":"13","author":"Yeung","year":"1988","journal-title":"Blood Cells"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0037","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/bjh.15435","article-title":"Dyserythropoiesis in the diagnosis of the myelodysplastic syndromes and other myeloid neoplasms: problem areas","volume":"182","author":"Goasguen","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0038","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1182\/blood-2016-11-752717","article-title":"Morphologic features of normoblasts in a case of myopathy, lactic acidosis, and sideroblastic anemia","volume":"129","author":"Li","year":"2017","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0039","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1093\/rheumatology\/keab225","article-title":"VEXAS syndrome: still expanding the clinical phenotype","volume":"60","author":"Oganesyan","year":"2021","journal-title":"Rheumatology"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0040","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","article-title":"Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1","volume":"5","author":"Obiorah","year":"2021","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0041","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/bjh.17679","article-title":"Vacuoles in neutrophil precursors in VEXAS syndrome: diagnostic performances and threshold","volume":"195","author":"Lacombe","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0042","first-page":"1","article-title":"Atypical splice site mutations causing VEXAS syndrome","volume":"524","author":"Templ\u00e9","year":"2021","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0043","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1371\/journal.pmed.0030297","article-title":"A proposed classification of the immunological diseases","volume":"3","author":"McGonagle","year":"2006","journal-title":"PLoS Med"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0044","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fimmu.2016.00502","article-title":"Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment","volume":"7","author":"Kovtonyuk","year":"2016","journal-title":"Front Immunol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0045","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1200\/JCO.2011.34.8540","article-title":"Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes","volume":"29","author":"Kristinsson","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0046","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3324\/haematol.11812","article-title":"Activation of cytotoxic T-cell receptor \u03b3\u03b4 T lymphocytes in response to specific stimulation in myelodysplastic syndromes","volume":"93","author":"Kiladjian","year":"2008","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0047","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.leu.2404590","article-title":"Prevalence and clinical association of clonal T-cell expansions in myelodysplastic syndrome","volume":"21","author":"Epling-Burnette","year":"2007","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0048","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1182\/blood-2005-04-1543","article-title":"Evidence for reduced B-cell progenitors in early (low-risk) myelodysplastic syndrome","volume":"106","author":"Sternberg","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0049","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.leu.2404080","article-title":"Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes","volume":"20","author":"Kiladjian","year":"2006","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2009.07593.x","article-title":"IL-17-producing CD4+ T cells, pro-inflammatory cytokines and apoptosis are increased in low risk myelodysplastic syndrome","volume":"145","author":"Kordasti","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0051","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/blood-2010-04-277921","article-title":"T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy","volume":"117","author":"Sloand","year":"2011","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0052","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.4049\/jimmunol.1200602","article-title":"Expansion of effector memory regulatory t-cells represents a novel prognostic factor in lower risk myelodysplastic syndrome","volume":"189","author":"Mailloux","year":"2012","journal-title":"J Immunol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0053","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1365-2141.2011.08683.x","article-title":"Role of immune responses in the pathogenesis of low-risk MDS and high-risk MDS: implications for immunotherapy","volume":"153","author":"Aggarwal","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0054","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2016.112","article-title":"The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia","volume":"17","author":"Sperling","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0055","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1182\/blood-2005-05-1884","article-title":"Interferon-\u03b3-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles","volume":"107","author":"Zeng","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0056","doi-asserted-by":"crossref","first-page":"6715","DOI":"10.1038\/sj.onc.1210756","article-title":"Cytokine receptors and hematopoietic differentiation","volume":"26","author":"Robb","year":"2007","journal-title":"Oncogene"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0057","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1182\/blood-2007-03-079681","article-title":"Hematopoietic cytokines","volume":"111","author":"Metcalf","year":"2008","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0058","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2005-05-1989","article-title":"NF-\u03baB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome","volume":"107","author":"Braun","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0059","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/leu.2015.69","article-title":"Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes","volume":"29","author":"Ga\u00f1\u00e1n-G\u00f3mez","year":"2015","journal-title":"Leukemia"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0060","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1182\/blood-2016-07-730556","article-title":"The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype","volume":"128","author":"Basiorka","year":"2016","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0061","doi-asserted-by":"crossref","first-page":"e26329","DOI":"10.4161\/onci.26329","article-title":"hTERT deficiency in na\u00efve T cells affects lymphocyte homeostasis in myelodysplastic syndrome patients","volume":"2","author":"Yang","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0062","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1158\/0008-5472.CAN-10-2933","article-title":"Reduced SMAD7 leads to overactivation of TGF-\u03b2 signaling in MDS that can be reversed by a specific inhibitor of TGF-\u03b2 receptor I kinase","volume":"71","author":"Zhou","year":"2011","journal-title":"Cancer Res"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0063","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V85.11.3183.bloodjournal85113183","article-title":"Fas antigen expression on CD34+ human marrow cells is induced by interferon \u03b3 and tumor necrosis factor \u03b1 and potentiates cytokine-mediated hematopoietic suppression in vitro","volume":"85","author":"Maciejewski","year":"1995","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0064","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1182\/blood.V99.5.1594","article-title":"In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis","volume":"99","author":"Claessens","year":"2002","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0065","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1172\/JCI67580","article-title":"Induction of myelodysplasia by myeloid-derived suppressor cells","volume":"123","author":"Chen","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0066","first-page":"3512","article-title":"A focused review of hematopoietic neoplasms occurring in the therapy-related setting","volume":"7","author":"Zhang","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0067","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ajcp\/106.5.676","article-title":"Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy","volume":"106","author":"Rosenthal","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0068","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/jamaoncol.2016.6435","article-title":"Association of therapy for autoimmune disease with myelodysplastic syndromes and acute myeloid leukemia","volume":"3","author":"Ertz-Archambault","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.610019","article-title":"Somatic mutations and the risk of undifferentiated autoinflammatory disease in MDS: an under-recognized but prognostically important complication","volume":"12","author":"Watad","year":"2021","journal-title":"Front Immunol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0070","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000355341","article-title":"Refractoriness of intestinal Beh\u00e7et's disease with myelodysplastic syndrome involving trisomy 8 to medical therapies -our case experience and review of the literature","volume":"88","author":"Toyonaga","year":"2013","journal-title":"Digestion"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0071","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/10428190109097683","article-title":"Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis \u2014 beh\u00e7et's syndrome","volume":"42","author":"Kimura","year":"2001","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0072","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1182\/blood.2021010811","article-title":"Vacuolization of hematopoietic precursors: an enigma with multiple etiologies","volume":"137","author":"Gurnari","year":"2021","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0073","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/bmt.2013.198","article-title":"Significant improvement of Takayasu arteritis after cord blood transplantation in a patient with myelodysplastic syndrome","volume":"49","author":"Kato","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0074","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.leukres.2016.02.005","article-title":"Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"43","author":"Fraison","year":"2016","journal-title":"Leuk Res"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0075","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3904\/kjim.2014.29.1.123","article-title":"Successful treatment of myelodysplastic syndrome and Behcet colitis after allogeneic hematopoietic stem cell transplantation","volume":"29","author":"Kook","year":"2014","journal-title":"Korean J Intern Med"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0076","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jbspin.2014.10.011","article-title":"Complete and sustained remission of spondyloarthritis after allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome","volume":"82","author":"Simonetta","year":"2015","journal-title":"Jt Bone Spine"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0077","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3324\/haematol.2012.074823","article-title":"The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndrome","volume":"98","author":"Costantini","year":"2013","journal-title":"Haematologica"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0078","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1182\/blood-2011-09-377044","article-title":"Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)","volume":"119","author":"Goodyear","year":"2012","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0079","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/bmt.2011.159","article-title":"Non-myeloablative allogenic BMT for myelodysplastic syndrome successfully controlled accompanying relapsing polychondritis","volume":"47","author":"Tomomatsu","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0080","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaci.2020.11.043","article-title":"HSCT is effective in patients with PSTPIP1-associated myeloid-related proteinemia inflammatory (PAMI) syndrome","volume":"148","author":"Laberko","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0081","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.autrev.2017.07.003","article-title":"Biologics in myelodysplastic syndrome-related systemic inflammatory and autoimmune diseases: french multicenter retrospective study of 29 patients","volume":"16","author":"Mekinian","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0082","article-title":"Mixed results with baricitinib in biological-resistant adult-onset Still's disease and undifferentiated systemic autoinflammatory disease, RMD Open Rheum","volume":"6","author":"Kacar","year":"2020","journal-title":"Musculoskelet Dis"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0083","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00277-018-3514-3","article-title":"Deciphering the prognostic significance of autoimmune disorders in myelodysplastic syndromes","volume":"98","author":"Fozza","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0084","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/cncr.23785","article-title":"The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes","volume":"113","author":"Tsimberidou","year":"2008","journal-title":"Cancer"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0085","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1182\/blood-2010-01-262071","article-title":"Recurrent expression signatures of cytokines and chemokines are present and are independently prognostic in acute myelogenous leukemia and myelodysplasia","volume":"116","author":"Kornblau","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0086","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1093\/rheumatology\/keab349","article-title":"Case of polychondritis-onset refractory organising pneumonia with cytopaenia diagnosed as VEXAS syndrome: the disease course of seven years","volume":"60","author":"Sakuma","year":"2021","journal-title":"Rheumatology"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0087","doi-asserted-by":"crossref","first-page":"e304","DOI":"10.1093\/rheumatology\/keab200","article-title":"A case of VEXAS syndrome manifesting as Kikuchi-Fujimoto disease, relapsing polychondritis, venous thromboembolism and macrocytic anaemia","volume":"60","author":"Lee","year":"2021","journal-title":"Rheumatology"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0088","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/ajh.26098","article-title":"Myeloid and lymphoid vacuolation in VEXAS syndrome","volume":"96","author":"Fan","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0089","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40164-021-00217-2","article-title":"VEXAS syndrome in myelodysplastic syndrome with autoimmune disorder","volume":"10","author":"Huang","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0090","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1093\/rheumatology\/keab211","article-title":"VEXAS syndrome in a patient with previous spondyloarthritis with a favourable response to intravenous immunoglobulin and anti-IL17 therapy","volume":"60","author":"Magnol","year":"2021","journal-title":"Rheumatology"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0091","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/bjh.17381","article-title":"Characteristic vacuolisation of granulocytic and erythroid precursors associated with VEXAS syndrome","volume":"194","author":"Rieu","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0092","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.7326\/L21-0023","article-title":"Severe Joint Involvement in VEXAS Syndrome: a case report","volume":"174","author":"Lacombe","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0093","article-title":"The VEXAS syndrome: uncontrolled inflammation and macrocytic anaemia in a 77-year-old male patient","volume":"8","author":"Himmelmann","year":"2021","journal-title":"Eur J Case Reports Intern Med"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0094","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2021.678927","article-title":"Case Report: VEXAS syndrome: from mild symptoms to life-threatening macrophage activation syndrome","volume":"12","author":"Staels","year":"2021","journal-title":"Front Immunol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0095","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s100670200081","article-title":"Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship?","volume":"21","author":"Espinosa","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0096","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/PL00011218","article-title":"Remitting seronegative symmetrical synovitis with pitting oedema: a study of 12 cases","volume":"21","author":"Paira","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0097","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1002\/art.23085","article-title":"Vasculitides associated with malignancies: analysis of sixty patients","volume":"57","author":"Fain","year":"2007","journal-title":"Arthritis Care Res"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0098","first-page":"1606","article-title":"Concurrent temporal (giant cell) arteritis and malignancy: report of 20 patients with review of the literature","volume":"33","author":"Liozon","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0099","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/rheumatology\/39.4.417","article-title":"Prevalence of rheumatic manifestations and antineutrophil cytoplasmic antibodies in haematological malignancies. a prospective study","volume":"39","author":"Hamidou","year":"2000","journal-title":"Rheumatology"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0100","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3899\/jrheum.210149","article-title":"Somatic Mutation in UBA1 and ANCA-associated Vasculitis","volume":"48","author":"Ross","year":"2021","journal-title":"J Rheumatol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0101","first-page":"e3091","article-title":"Certain autoimmune manifestations are associated with distinctive karyotypes and outcomes in patients with myelodysplastic syndrome: a retrospective cohort study","volume":"95","author":"Lee","year":"2016","journal-title":"Me. (United States)"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0102","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/iwj.12463","article-title":"Patients with pyoderma gangrenosum \u2013 analyses of the german drg data from 2012","volume":"13","author":"Jockenh\u00f6fer","year":"2016","journal-title":"Int Wound J"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0103","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.autrev.2018.07.009","article-title":"Autoimmune diseases in myelodysplastic syndrome favors patients survival: a case control study and literature review","volume":"18","author":"Seguier","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0104","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1365-2257.1991.tb00257.x","article-title":"Coombs negative haemolytic anaemia responding to intravenous immunoglobulins in a patient with myelodysplastic syndrome","volume":"13","author":"Van Rhee","year":"1991","journal-title":"Clin Lab Haematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0105","doi-asserted-by":"crossref","first-page":"E280","DOI":"10.1002\/ajh.24333","article-title":"Autoimmune diseases and myelodysplastic syndromes","volume":"91","author":"Komrokji","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0106","article-title":"VEXAS syndrome with systemic lupus erythematosus-expanding the spectrum of associated conditions","author":"Sharma","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0107","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1385\/MO:23:3:385","article-title":"Immunologic abnormalities in myelodysplastic syndromes: clinical features and characteristics of the lymphoid population","volume":"23","author":"Marisavljevi\u0107","year":"2006","journal-title":"Med Oncol"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0108","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s10620-007-0090-0","article-title":"Concurrent inflammatory bowel disease and myelodysplastic syndrome: Report of nine new cases and a review of the literature","volume":"53","author":"Wang","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.seminhematol.2021.10.003_bib0109","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000262292","article-title":"Pulmonary alveolar proteinosis as a terminal complication in a case of myelodysplastic syndrome with idic(20q-)","volume":"123","author":"Xue","year":"2009","journal-title":"Acta Haematol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196321000494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196321000494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T06:27:52Z","timestamp":1758522472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196321000494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":109,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0037196321000494"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2021.10.003","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Looking beyond VEXAS: Coexistence of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2021.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}